117.34 USD

Opening hours: 09:30 - 16:00 (Eastern Standard Time: 11/22/2024 12:45:27 PM)
Exchange open, closes in 3 hours 14 minutes
-0.09 USD (-0.09%)
1.53 USD (1.53%)
1.40 USD (1.40%)
14.36 USD (14.36%)
16.51 USD (16.51%)
51.00 USD (51.00%)
203.19 USD (203.19%)
612.07 USD (612.07%)

About Abbott Laboratories

Market Capitalization 201.02B

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois.

Headquarters (address)

100 Abbott Park Road

North Chicago 60064-6400 IL

United States

Phone224 667 6100
Websitehttps://www.abbott.com
Employees114,000
SectorHealthcare
IndustryMedical Devices
TickerABT
ExchangeNew York Stock Exchange
CurrencyUSD
52 week range99.71 - 121.64
Market Capitalization201.02B
Dividend yield forward1.90 %
Dividend yield forward United States (ID:6, base:1864) 4.21 %
P/E trailing35.23
P/E forward22.46
Price/Sale4.88
Price/Book5.05
Beta0.722
EPS3.29
EPS United States (ID:6, base:3395) 24.30

Dividend growth streak

Abbott Laboratories has raised their dividend 10.00 years in a row. This is above the 4.481461 year average in the 'Medical Devices' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Abbott Laboratories has raised their dividend 1.90 years in a row. This is below the 41168.084500 year average in the 'Medical Devices' industry

Compound Average Growth Rate 3 Years

Compound Average Growth Rate 3 Years: Abbott Laboratories has raised their dividend 12.31 years in a row. This is below the 24.005000 year average in the 'Medical Devices' industry

Compound Average Growth Rate 5 Years

Compound Average Growth Rate 5 Years: Abbott Laboratories has raised their dividend 12.74 years in a row. This is above the 12.571400 year average in the 'Medical Devices' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: Abbott Laboratories has raised their dividend 13.80 years in a row. This is above the 10.153400 year average in the 'Medical Devices' industry

Payout Ratio

Payout Ratio: Abbott Laboratories has raised their dividend 65.65 years in a row. This is below the 147.100200 year average in the 'Medical Devices' industry

Dividend growth streak

Abbott Laboratories has raised their dividend 10.00 years in a row. This is above the 4.481461 year average in the 'Medical Devices' industry

Forward Annual Dividend Yield

Forward Annual Dividend Yield: Abbott Laboratories has raised their dividend 1.90 years in a row. This is below the 41168.084500 year average in the 'Medical Devices' industry

Compound Average Growth Rate 3 Years

Compound Average Growth Rate 3 Years: Abbott Laboratories has raised their dividend 12.31 years in a row. This is below the 24.005000 year average in the 'Medical Devices' industry

Compound Average Growth Rate 5 Years

Compound Average Growth Rate 5 Years: Abbott Laboratories has raised their dividend 12.74 years in a row. This is above the 12.571400 year average in the 'Medical Devices' industry

Compound Average Growth Rate 10 Years

Compound Average Growth Rate 10 Years: Abbott Laboratories has raised their dividend 13.80 years in a row. This is above the 10.153400 year average in the 'Medical Devices' industry

Payout Ratio

Payout Ratio: Abbott Laboratories has raised their dividend 65.65 years in a row. This is below the 147.100200 year average in the 'Medical Devices' industry

CleverShares.com|
2024 ©

1.0.9092.25789